Autonomic Nervous System Drugs — MCQs

Q: Which of the following drugs binds only with the anionic site of cholinesterase?

Edrophonium. ### Explanation The enzyme **Acetylcholinesterase (AChE)** possesses two primary binding domains: the **anionic site** (which attracts the positive quaternary ammonium group of acetylcholine) and the **esteratic site** (where the actual hydrolysis occurs). #### Why Edrophonium is Correct **Edrophonium** is a quaternary ammonium compound that binds **reversibly and non-covalently** only to the **anionic site** of the enzyme via electrostatic attraction. Because it does not form a covalent bond with the esteratic site, its binding is very weak and short-lived. This explains its rapid onset and very short duration of action (5–15 minutes). #### Why Other Options are Incorrect * **Physostigmine, Neostigmine, and Pyridostigmine** are **Carbamates**. These drugs are "substrate substitutes." They bind to **both the anionic and the esteratic sites**. * Unlike Edrophonium, they covalently transfer a carbamoyl group to the esteratic site (carbamoylation). This bond is much more stable than the simple ionic attraction of Edrophonium, leading to a longer duration of action (0.5 to 6 hours). * **Physostigmine** is a tertiary amine (crosses BBB), while **Neostigmine** and **Pyridostigmine** are quaternary amines (do not cross BBB). #### NEET-PG High-Yield Pearls * **Tensilon Test:** Edrophonium was historically used to diagnose Myasthenia Gravis (MG) due to its rapid action. A brief improvement in muscle strength indicates a positive test. * **Differentiation:** It is also used to differentiate between a **Myasthenic crisis** (improvement with Edrophonium) and a **Cholinergic crisis** (worsening with Edrophonium). * **Drug of Choice:** Pyridostigmine is the DOC for the long-term oral treatment of Myasthenia Gravis. * **Antidote:** Physostigmine is the specific antidote for Atropine (anticholinergic) poisoning.

Q: Which of the following drugs does not cross the blood-brain barrier?

Glycopyrrolate. **Explanation:** The ability of a drug to cross the blood-brain barrier (BBB) is primarily determined by its chemical structure—specifically, whether it is a **quaternary ammonium compound** or a **tertiary amine**. **1. Why Glycopyrrolate is the correct answer:** Glycopyrrolate is a **quaternary ammonium compound**. These molecules are permanently charged (ionized) at physiological pH and are highly polar. Because the BBB is a lipid-rich membrane, polar/ionized drugs cannot diffuse across it. Therefore, Glycopyrrolate lacks central nervous system (CNS) side effects, making it ideal for reducing secretions pre-operatively without causing sedation or cognitive impairment. **2. Why the other options are incorrect:** * **Atropine & Scopolamine:** These are **tertiary amines**. They are non-ionized and lipid-soluble, allowing them to cross the BBB easily. Scopolamine, in particular, has significant CNS effects (sedation, amnesia) and is used for motion sickness. * **Promethazine:** This is a first-generation H1-antihistamine with strong anticholinergic properties. It is highly lipophilic and crosses the BBB readily, which is why it causes significant sedation. **Clinical Pearls for NEET-PG:** * **Mnemonic:** "Quaternary stays in the Quarters" (does not cross BBB). Examples: Glycopyrrolate, Ipratropium, Tiotropium, Neostigmine. * **Physostigmine vs. Neostigmine:** This is a classic comparison. Physostigmine (Tertiary) crosses the BBB and is used to treat Atropine toxicity. Neostigmine (Quaternary) does not cross the BBB. * **Clinical Choice:** Glycopyrrolate is preferred over Atropine in anesthesia when only peripheral muscarinic blockade is desired (e.g., to prevent bradycardia during reversal of neuromuscular blockade).

Q: Which of the following is NOT an alpha-adrenoceptor agonist?

Isoxsuprine. **Explanation:** The correct answer is **Isoxsuprine** because it is a **selective Beta-2 (β₂) adrenoceptor agonist**, not an alpha-agonist. It also possesses some direct vasodilator properties. **1. Why Isoxsuprine is the correct answer:** Isoxsuprine acts primarily on β₂ receptors in the smooth muscles of blood vessels and the uterus. Historically, it was used as a **tocolytic** (to delay premature labor) and a peripheral vasodilator. Since the question asks for the drug that is *NOT* an alpha-agonist, Isoxsuprine fits the criteria. **2. Analysis of incorrect options (Alpha-agonists):** * **Clonidine:** A prototypical **selective Alpha-2 (α₂) agonist**. It acts centrally to decrease sympathetic outflow, used primarily in hypertension and opioid withdrawal. * **Methyldopa:** A centrally acting **Alpha-2 (α₂) agonist**. It is a prodrug converted to α-methylnorepinephrine, which stimulates central α₂ receptors. It is the drug of choice for hypertension in pregnancy. * **Guanabenz:** Similar to clonidine, it is a **selective Alpha-2 (α₂) agonist** used for antihypertensive therapy. **High-Yield Clinical Pearls for NEET-PG:** * **Central α₂ Agonists:** Clonidine, Methyldopa, Guanfacine, and Guanabenz. They are used to treat hypertension by reducing central sympathetic tone. * **Tocolytics Mnemonic:** "It's Not My Time" (**I**ndomethacin, **N**ifedipine, **M**agnesium sulfate, **T**erbutaline/Ritodrine/Isoxsuprine). * **Isoxsuprine** is now less commonly used as a tocolytic due to the preference for more selective agents like Nifedipine or Atosiban. * **Methyldopa Side Effect:** Positive Coombs test (autoimmune hemolytic anemia).

Q: Which of the following is a long-acting non-depolarizing competitive blocker?

Doxacurium. **Explanation:** Neuromuscular blockers (NMBs) are classified based on their mechanism of action and duration of effect. Non-depolarizing blockers act as competitive antagonists at the nicotinic receptors ($N_m$) of the neuromuscular junction. **1. Why Doxacurium is correct:** Doxacurium belongs to the **Benzylisoquinolinium** class. It is characterized as a **long-acting** agent with a duration of action typically exceeding 60–90 minutes. It is highly potent and lacks significant cardiovascular side effects (no histamine release), making it suitable for long surgical procedures. **2. Why the other options are incorrect:** * **Rocuronium:** This is an **intermediate-acting** steroid-based NMB. It is notable for its rapid onset of action, making it the preferred alternative to Succinylcholine for Rapid Sequence Induction (RSI). * **Mivacurium:** This is a **short-acting** benzylisoquinolinium. It is unique because it is metabolized by plasma cholinesterase (like Succinylcholine), leading to a brief duration of action (approx. 15–20 mins). * **Atracurium:** This is an **intermediate-acting** agent. It is famous for undergoing **Hofmann Elimination** (spontaneous non-enzymatic degradation), making it safe for patients with liver or kidney failure. **High-Yield Clinical Pearls for NEET-PG:** * **Longest acting NMB:** Pancuronium or Doxacurium. * **Shortest acting Non-depolarizing NMB:** Mivacurium. * **Drug of choice in Renal/Hepatic failure:** Atracurium or Cisatracurium (due to Hofmann elimination). * **Laudanosine Toxicity:** A metabolite of Atracurium that can cross the BBB and cause seizures. * **Reversal Agent:** Sugammadex is specifically used to reverse "onium" drugs (Rocuronium > Vecuronium).

Q: Which of the following is a relatively cerebroselective anticholinesterase found to afford symptomatic improvement in Alzheimer's disease?

Donepezil. ### Explanation **Correct Option: A. Donepezil** Alzheimer’s disease is characterized by a cholinergic deficiency in the brain. **Donepezil** is a reversible, long-acting, and **relatively cerebroselective** (central-acting) acetylcholinesterase (AChE) inhibitor. Its high affinity for AChE in the brain compared to the periphery minimizes systemic side effects. By inhibiting the breakdown of acetylcholine in the synaptic cleft, it enhances cholinergic transmission, providing symptomatic improvement in cognitive function. Other drugs in this class include Rivastigmine and Galantamine. **Analysis of Incorrect Options:** * **B. Pyridostigmine:** This is a quaternary ammonium compound that does not cross the blood-brain barrier (BBB). It is used primarily for **Myasthenia Gravis** to act on the nicotinic receptors at the neuromuscular junction. * **C. Pyritinol:** Also known as Pyrithioxine, it is a semi-synthetic water-soluble analog of Vitamin B6. It is classified as a **nootropic** (cognitive enhancer) but is not an anticholinesterase and is not the first-line treatment for Alzheimer’s. * **D. Gemfibrozil:** This is a **fibrate** used as a hypolipidemic agent. It activates PPAR-α to lower triglyceride levels and has no role in the cholinergic system or Alzheimer’s management. **High-Yield Clinical Pearls for NEET-PG:** * **Rivastigmine:** A "pseudo-irreversible" inhibitor that inhibits both AChE and Butyrylcholinesterase (BuChE). It is available as a **transdermal patch** to reduce GI side effects. * **Galantamine:** Also acts as a **nicotinic receptor modulator**, enhancing the action of acetylcholine. * **Memantine:** An **NMDA receptor antagonist** often used in moderate-to-severe Alzheimer’s, frequently as an adjunct to Donepezil. * **Side Effects:** Common side effects of central AChE inhibitors include "SLUDGE" symptoms (diarrhea, nausea, bradycardia, and insomnia).

Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs

Question 1: Which of the following drugs binds only with the anionic site of cholinesterase?

A. Physostigmine
B. Neostigmine
C. Edrophonium (Correct Answer)
D. Pyridostigmine

Explanation: ### Explanation The enzyme **Acetylcholinesterase (AChE)** possesses two primary binding domains: the **anionic site** (which attracts the positive quaternary ammonium group of acetylcholine) and the **esteratic site** (where the actual hydrolysis occurs). #### Why Edrophonium is Correct **Edrophonium** is a quaternary ammonium compound that binds **reversibly and non-covalently** only to the **anionic site** of the enzyme via electrostatic attraction. Because it does not form a covalent bond with the esteratic site, its binding is very weak and short-lived. This explains its rapid onset and very short duration of action (5–15 minutes). #### Why Other Options are Incorrect * **Physostigmine, Neostigmine, and Pyridostigmine** are **Carbamates**. These drugs are "substrate substitutes." They bind to **both the anionic and the esteratic sites**. * Unlike Edrophonium, they covalently transfer a carbamoyl group to the esteratic site (carbamoylation). This bond is much more stable than the simple ionic attraction of Edrophonium, leading to a longer duration of action (0.5 to 6 hours). * **Physostigmine** is a tertiary amine (crosses BBB), while **Neostigmine** and **Pyridostigmine** are quaternary amines (do not cross BBB). #### NEET-PG High-Yield Pearls * **Tensilon Test:** Edrophonium was historically used to diagnose Myasthenia Gravis (MG) due to its rapid action. A brief improvement in muscle strength indicates a positive test. * **Differentiation:** It is also used to differentiate between a **Myasthenic crisis** (improvement with Edrophonium) and a **Cholinergic crisis** (worsening with Edrophonium). * **Drug of Choice:** Pyridostigmine is the DOC for the long-term oral treatment of Myasthenia Gravis. * **Antidote:** Physostigmine is the specific antidote for Atropine (anticholinergic) poisoning.

Question 2: Which of the following drugs does not cross the blood-brain barrier?

A. Glycopyrrolate (Correct Answer)
B. Atropine
C. Scopolamine
D. Promethazine

Explanation: **Explanation:** The ability of a drug to cross the blood-brain barrier (BBB) is primarily determined by its chemical structure—specifically, whether it is a **quaternary ammonium compound** or a **tertiary amine**. **1. Why Glycopyrrolate is the correct answer:** Glycopyrrolate is a **quaternary ammonium compound**. These molecules are permanently charged (ionized) at physiological pH and are highly polar. Because the BBB is a lipid-rich membrane, polar/ionized drugs cannot diffuse across it. Therefore, Glycopyrrolate lacks central nervous system (CNS) side effects, making it ideal for reducing secretions pre-operatively without causing sedation or cognitive impairment. **2. Why the other options are incorrect:** * **Atropine & Scopolamine:** These are **tertiary amines**. They are non-ionized and lipid-soluble, allowing them to cross the BBB easily. Scopolamine, in particular, has significant CNS effects (sedation, amnesia) and is used for motion sickness. * **Promethazine:** This is a first-generation H1-antihistamine with strong anticholinergic properties. It is highly lipophilic and crosses the BBB readily, which is why it causes significant sedation. **Clinical Pearls for NEET-PG:** * **Mnemonic:** "Quaternary stays in the Quarters" (does not cross BBB). Examples: Glycopyrrolate, Ipratropium, Tiotropium, Neostigmine. * **Physostigmine vs. Neostigmine:** This is a classic comparison. Physostigmine (Tertiary) crosses the BBB and is used to treat Atropine toxicity. Neostigmine (Quaternary) does not cross the BBB. * **Clinical Choice:** Glycopyrrolate is preferred over Atropine in anesthesia when only peripheral muscarinic blockade is desired (e.g., to prevent bradycardia during reversal of neuromuscular blockade).

Question 3: Which of the following is NOT an alpha-adrenoceptor agonist?

A. Clonidine
B. Methyldopa
C. Guanabenz
D. Isoxsuprine (Correct Answer)

Explanation: **Explanation:** The correct answer is **Isoxsuprine** because it is a **selective Beta-2 (β₂) adrenoceptor agonist**, not an alpha-agonist. It also possesses some direct vasodilator properties. **1. Why Isoxsuprine is the correct answer:** Isoxsuprine acts primarily on β₂ receptors in the smooth muscles of blood vessels and the uterus. Historically, it was used as a **tocolytic** (to delay premature labor) and a peripheral vasodilator. Since the question asks for the drug that is *NOT* an alpha-agonist, Isoxsuprine fits the criteria. **2. Analysis of incorrect options (Alpha-agonists):** * **Clonidine:** A prototypical **selective Alpha-2 (α₂) agonist**. It acts centrally to decrease sympathetic outflow, used primarily in hypertension and opioid withdrawal. * **Methyldopa:** A centrally acting **Alpha-2 (α₂) agonist**. It is a prodrug converted to α-methylnorepinephrine, which stimulates central α₂ receptors. It is the drug of choice for hypertension in pregnancy. * **Guanabenz:** Similar to clonidine, it is a **selective Alpha-2 (α₂) agonist** used for antihypertensive therapy. **High-Yield Clinical Pearls for NEET-PG:** * **Central α₂ Agonists:** Clonidine, Methyldopa, Guanfacine, and Guanabenz. They are used to treat hypertension by reducing central sympathetic tone. * **Tocolytics Mnemonic:** "It's Not My Time" (**I**ndomethacin, **N**ifedipine, **M**agnesium sulfate, **T**erbutaline/Ritodrine/Isoxsuprine). * **Isoxsuprine** is now less commonly used as a tocolytic due to the preference for more selective agents like Nifedipine or Atosiban. * **Methyldopa Side Effect:** Positive Coombs test (autoimmune hemolytic anemia).

Question 4: Which of the following is a long-acting non-depolarizing competitive blocker?

A. Doxacurium (Correct Answer)
B. Rocuronium
C. Mivacurium
D. Atracurium

Explanation: **Explanation:** Neuromuscular blockers (NMBs) are classified based on their mechanism of action and duration of effect. Non-depolarizing blockers act as competitive antagonists at the nicotinic receptors ($N_m$) of the neuromuscular junction. **1. Why Doxacurium is correct:** Doxacurium belongs to the **Benzylisoquinolinium** class. It is characterized as a **long-acting** agent with a duration of action typically exceeding 60–90 minutes. It is highly potent and lacks significant cardiovascular side effects (no histamine release), making it suitable for long surgical procedures. **2. Why the other options are incorrect:** * **Rocuronium:** This is an **intermediate-acting** steroid-based NMB. It is notable for its rapid onset of action, making it the preferred alternative to Succinylcholine for Rapid Sequence Induction (RSI). * **Mivacurium:** This is a **short-acting** benzylisoquinolinium. It is unique because it is metabolized by plasma cholinesterase (like Succinylcholine), leading to a brief duration of action (approx. 15–20 mins). * **Atracurium:** This is an **intermediate-acting** agent. It is famous for undergoing **Hofmann Elimination** (spontaneous non-enzymatic degradation), making it safe for patients with liver or kidney failure. **High-Yield Clinical Pearls for NEET-PG:** * **Longest acting NMB:** Pancuronium or Doxacurium. * **Shortest acting Non-depolarizing NMB:** Mivacurium. * **Drug of choice in Renal/Hepatic failure:** Atracurium or Cisatracurium (due to Hofmann elimination). * **Laudanosine Toxicity:** A metabolite of Atracurium that can cross the BBB and cause seizures. * **Reversal Agent:** Sugammadex is specifically used to reverse "onium" drugs (Rocuronium > Vecuronium).

Question 5: Which of the following is a relatively cerebroselective anticholinesterase found to afford symptomatic improvement in Alzheimer's disease?

A. Donepezil (Correct Answer)
B. Pyridostigmine
C. Pyritinol
D. Gemfibrozil

Explanation: ### Explanation **Correct Option: A. Donepezil** Alzheimer’s disease is characterized by a cholinergic deficiency in the brain. **Donepezil** is a reversible, long-acting, and **relatively cerebroselective** (central-acting) acetylcholinesterase (AChE) inhibitor. Its high affinity for AChE in the brain compared to the periphery minimizes systemic side effects. By inhibiting the breakdown of acetylcholine in the synaptic cleft, it enhances cholinergic transmission, providing symptomatic improvement in cognitive function. Other drugs in this class include Rivastigmine and Galantamine. **Analysis of Incorrect Options:** * **B. Pyridostigmine:** This is a quaternary ammonium compound that does not cross the blood-brain barrier (BBB). It is used primarily for **Myasthenia Gravis** to act on the nicotinic receptors at the neuromuscular junction. * **C. Pyritinol:** Also known as Pyrithioxine, it is a semi-synthetic water-soluble analog of Vitamin B6. It is classified as a **nootropic** (cognitive enhancer) but is not an anticholinesterase and is not the first-line treatment for Alzheimer’s. * **D. Gemfibrozil:** This is a **fibrate** used as a hypolipidemic agent. It activates PPAR-α to lower triglyceride levels and has no role in the cholinergic system or Alzheimer’s management. **High-Yield Clinical Pearls for NEET-PG:** * **Rivastigmine:** A "pseudo-irreversible" inhibitor that inhibits both AChE and Butyrylcholinesterase (BuChE). It is available as a **transdermal patch** to reduce GI side effects. * **Galantamine:** Also acts as a **nicotinic receptor modulator**, enhancing the action of acetylcholine. * **Memantine:** An **NMDA receptor antagonist** often used in moderate-to-severe Alzheimer’s, frequently as an adjunct to Donepezil. * **Side Effects:** Common side effects of central AChE inhibitors include "SLUDGE" symptoms (diarrhea, nausea, bradycardia, and insomnia).

Practice by Chapter

Cholinergic Agonists

Practice Questions

Cholinergic Antagonists

Practice Questions

Adrenergic Agonists

Practice Questions

Adrenergic Antagonists

Practice Questions

Ganglionic Agents

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Autonomic Drugs in Ophthalmology

Practice Questions

Autonomic Drugs in Cardiovascular Disease

Practice Questions

Autonomic Drugs in Respiratory Disease

Practice Questions

Autonomic Drugs in Urological Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free